Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Income towards Parent Company (2020 - 2025)

Arcutis Biotherapeutics has reported Income towards Parent Company over the past 6 years, most recently at $17.4 million for Q4 2025.

  • Quarterly results put Income towards Parent Company at $17.4 million for Q4 2025, up 260.98% from a year ago — trailing twelve months through Dec 2025 was -$16.2 million (up 88.45% YoY), and the annual figure for FY2025 was -$16.2 million, up 88.45%.
  • Income towards Parent Company for Q4 2025 was $17.4 million at Arcutis Biotherapeutics, up from $7.4 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for ARQT hit a ceiling of $17.4 million in Q4 2025 and a floor of -$107.7 million in Q3 2022.
  • Median Income towards Parent Company over the past 5 years was -$48.5 million (2023), compared with a mean of -$46.8 million.
  • Biggest five-year swings in Income towards Parent Company: tumbled 109.27% in 2021 and later soared 260.98% in 2025.
  • Arcutis Biotherapeutics' Income towards Parent Company stood at -$71.3 million in 2021, then fell by 1.03% to -$72.0 million in 2022, then grew by 7.98% to -$66.3 million in 2023, then skyrocketed by 83.72% to -$10.8 million in 2024, then soared by 260.98% to $17.4 million in 2025.
  • The last three reported values for Income towards Parent Company were $17.4 million (Q4 2025), $7.4 million (Q3 2025), and -$15.9 million (Q2 2025) per Business Quant data.